Max Healthcare Institute Limited Earnings Summary — Q4 FY2026
Max Healthcare Delivers Robust Q4 Growth with Revenue Exceeding ₹2,100 Crore and Improved Margins
Key Takeaways
- Revenue surpassed ₹2,100 crore in Q4 FY26, representing a 12.2% growth compared to the same quarter last year.
- Operating Profit Margin improved to 28%, benefiting from lower operating expenses relative to revenue growth.
- Net Profit surged 13.6% sequentially from Q3 FY26, reaching ₹342 crore.
- The company maintained strong profitability despite an increase in interest costs, which rose to ₹67 crore in the current quarter.
- Depreciation saw an uptick to ₹123 crore, reflecting recent capital expenditures and brownfield expansions.
- Other income recovered significantly in Q4 to ₹48 crore from a negative value in the previous quarter.
- Tax rate returned to a normalized level of 26% after an outlier negative tax rate in Q2 FY26.
Management Guidance
Management remains focused on aggressive brownfield expansion and premium positioning in metro hubs to maintain industry-leading ARPOB (Average Revenue Per Occupied Bed).
Sentiment Shift
Improving
Margins and bottom-line performance showed a strong recovery in Q4 following a relatively weaker performance in Q3.
Outlook
The outlook remains strong as the company continues to scale revenue towards ₹8,300+ Cr annually with a negative cash conversion cycle and strategic presence in high-demand urban markets.
From the Annual Report (Key Quotes)
“Max Healthcare Institute has evolved into India’s largest hospital chain by market capitalization.”
“Management focus remains on premiumization and digital transformation to drive patient stickiness.”
“The shift toward an institutional-led structure shows a transition toward a professionally managed entity.”
Earnings Call Transcript — Q4 FY2026
Transcript is fetched on demand to save crawl credits. Click below to load the latest earnings call transcript for this quarter.
This summary is AI-generated from Max Healthcare Institute Limited's latest quarterly filing and earnings call. For informational purposes only — not investment advice.